From a study that analyzed the therapeutic dilemma of treating acute leukemia (AL) during pregnancy and the delicate balance of improving maternal and fetal outcomes, investigators determined that ...

SAITAMA—A teenager died and two other young patients suffered serious complications following a suspected drug mix-up during ...

Key opportunities in the B-cell inhibitors market for non-oncology diseases include the rising demand for targeted immunomodulatory therapies, driven by increasing autoimmune disorder prevalence.

Following spinal injections of anticancer drugs last year at Saitama Prefectural Children’s Medical Center, one leukemia patient in his teens died and the condition of two other patients became ...

BTK inhibitor monotherapy is foundational across several B-cell malignancies, with newer, more selective agents designed to preserve efficacy while improving tolerability relative to first-in-class ...

One teenage leukemia patient died and two others have fallen unconscious after undergoing chemotherapy injections at a children's hospital near Tokyo, local media reported on Thursday. The Saitama ...

When his father was diagnosed with leukaemia in 2025, a 10-year-old Malaysian boy stepped up to be his stem cell donor through a bone marrow transplant. It was the only way doctors said his father ...

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

The Eagles acquired Metchie and a 2026 sixth-round draft pick from the Texans for tight end Harrison Bryant and a 2026 fifth-round draft pick in August. On October, Philadelphia sent Metchie and a ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next segment on its CEO Corner, a platform featuring Walter Klemp, Chief Executive Officer.

A team of Santa Barbara high school students leading a fundraising campaign for Blood Cancer United will host a community fundraiser Wednesday, March 18 ...